¾È³çÇϼ¼¿ä ö±ÕÀÔ´Ï´Ù.
À̹ø Åä¿äÀÏ ¹ßÇ¥ ¼¼¹Ì³ª¿¡¼ Á¦°¡ ¹ßÇ¥ µå¸± ³í¹®Àº Áö³ÇØ 7¿ù¿¡ , ACS Nano(IF : 13.9) ¿¡ ÃâÆÇ µÈ,
In Situ Manipulation of Dendritic Cells by an Autophagy-Regulative Nanoactivator Enables Effective Cancer Immunotherapy
¶ó´Â Á¦¸ñÀÇ ³í¹®ÀÔ´Ï´Ù.
autophagy¸¦ À¯µµÇÒ ¼ö ÀÖ´Â bec-1 peptide¸¦ Æ÷ÇÔÇÑ nanovaccineÀ» ÀÌ¿ëÇÏ¿©, È¿°úÀûÀ¸·Î DCÀÇ Ç׿øÁ¦½Ã ´É·ÂÀ» ³ôÀÌ°í
CD8+ T cell response¸¦ À¯µµÇÏ´Â °ÍÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù.
³í¹®¿¡¼´Â cross-presentationÀ» ¾ð±ÞÇÏ°í ÀÖÁö¸¸, ÇØ´ç ¹é½Å¿¡¼ »ç¿ëÇÑ OVA´Â MHC I ¿¡ ·Îµù µÈ´Ù°í ¾Ë·ÁÁø epitopeÀÎ
SIINFEKL peptide¸¦ »ç¿ëÇÏ°í Àֱ⠶§¹®¿¡, processing independent ÇÏ´Ù´Â Á¡¿¡¼ ¸ÍÁ¤ÀÌ Àֱ⵵ ÇÕ´Ï´Ù.
Åä¿äÀÏ¿¡ ºËµµ·Ï ÇÏ°Ú½À´Ï´Ù.
³í¹®¸µÅ© : https://pubs.acs.org/doi/10.1021/acsnano.9b00143